Quest Diagnostics and Lee Health, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors. Under the agreement Quest will provide supply chain expertise in laboratory equipment, supplies and procurement processes for five hospitals owned by Lee Health and selected outpatient centers. Quest will also continue to perform reference testing for Lee Health.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
134.3 USD | -0.86% | +4.53% | -2.63% |
Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
Apr. 24 | Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.63% | 15.04B | |
-14.92% | 84.87B | |
+13.30% | 83.08B | |
+10.92% | 29.4B | |
-12.71% | 16.72B | |
-3.06% | 16.4B | |
-3.97% | 11.88B | |
-1.42% | 11.88B | |
-31.75% | 11.86B | |
+27.44% | 11.64B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Teams Up with Lee Health to Deliver High-Value, Innovative Laboratory Services